Emergent BioSolutions CEO to retire; replacement named

In This List

Blog

Insight Weekly: Recession risk persists; Banks pull back from crypto; 2022 laggard stocks rally

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: Inflation eases; bank M&A slows; top companies boost market share

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

7 Jan, 2019

Author Angelee Tabios
Theme Healthcare & Pharmaceuticals

Emergent BioSolutions Inc. said Daniel Abdun-Nabi is retiring as the company's CEO and board member.

Abdun-Nabi has been the company's CEO since April 2012.

Robert Kramer, the company's current president and COO, will replace Abdun-Nabi. Effective April 1, Kramer will assume the president and CEO roles. He will also assume Abdun-Nabi's board seat.

Gaithersburg, Md.-based Emergent BioSolutions is a life sciences company developing specialty products to address public health threats.